<br>Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them</br><em> – by Jack Stone and Maria Laura Ciusa</em>

Knowledge sharing for antimicrobial research: AntibioticDB and SPARK and why researchers should use them – by Jack Stone and Maria Laura ...

5 August 2020
<br>Getting the most out of antimicrobial surveillance</br><em> – by Mariana Castanheira</em>

Getting the most out of antimicrobial surveillance – by Mariana Castanheira

28 May 2020
<br>COVID-19 and antimicrobial resistance: Are there any unknowns that will become known?</br><em> – by Stephan Harbarth</em>

COVID-19 and antimicrobial resistance: Are there any unknowns that will become known? – by Stephan Harbarth

13 May 2020
<br>COVID-19 and its impact on antimicrobial stewardship</br><em> – by Andrew Seaton</em>

COVID-19 and its impact on antimicrobial stewardship – by Andrew Seaton

30 April 2020
<br>The critical need for alternative approaches to address antibiotic treatment failure</br><em> – by Bob Hancock</em>

The critical need for alternative approaches to address antibiotic treatment failure – by Bob Hancock

16 April 2020
<br>COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever</br><em> – by Manica Balasegaram</em>

COVID-19 and why tackling the silent crisis of drug-resistant infections matters more than ever – by Manica Balasegaram

2 April 2020
<br>The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation</br><em> – by Ryan Cirz and Kevin Krause</em>

The antibiotics marketplace collapse: It’s just math, and it’s a solvable equation – by Ryan Cirz and Kevin Krause

17 March 2020
<br>Diagnostics to safeguard new and current antibiotics for gonorrhoea</br><em> – by Cassandra Kelly-Cirino and Cecilia Ferreyra</em>

Diagnostics to safeguard new and current antibiotics for gonorrhoea – by Cassandra Kelly-Cirino and Cecilia Ferreyra

22 January 2020
<br>On fireworks and finding ways to address drug-resistance in low- and middle-income countries</br><em> – by Ramanan Laxminarayan</em>

On fireworks and finding ways to address drug-resistance in low- and middle-income countries – by Ramanan Laxminarayan

16 December 2019
<br>Bringing antimicrobial research and development to Africa – the time is now</br><em> – by Greg Basarab and Kelly Chibale</em>

Bringing antimicrobial research and development to Africa – the time is now – by Greg Basarab and Kelly Chibale

3 December 2019
<br>Talking about the ‘antibiotic apocalypse’ won’t encourage public action – here’s why</br><em> – by Tim Jinks</em>

Talking about the ‘antibiotic apocalypse’ won’t encourage public action – here’s why – by Tim Jinks

19 November 2019
<br>A new cephalosporin has been approved</br><em> – by Ursula Theuretzbacher</em>

A new cephalosporin has been approved – by Ursula Theuretzbacher

15 November 2019